MusclePharm (OTCMKTS:MSLP) Stock Price Crosses Below 200-Day Moving Average of $0.20
MusclePharm (OTCMKTS:MSLP) Stock Price Crosses Below 200-Day Moving Average of $0.20
MusclePharm Co. (OTCMKTS:MSLP – Get Rating) shares crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.20 and traded as low as $0.11. MusclePharm shares last traded at $0.23, with a volume of 10,774 shares traded.
在週二的交易中,MusclePharm Co.(場外交易代碼:MSLP-GET Rating)的股價跌破了200日移動均線。該股的200日移動均線切入位為0.20美元,交易價格低至0.11美元。MusclePharm的股票最新報0.23美元,總成交量為10,774股。
MusclePharm Price Performance
MusclePharm的性價比
The firm has a market capitalization of $7.65 million, a price-to-earnings ratio of -0.39 and a beta of 0.38. The firm has a 50 day moving average price of $0.17 and a 200-day moving average price of $0.20.
該公司的市值為765萬美元,市盈率為-0.39,貝塔係數為0.38。該公司的50日移動均線價格為0.17美元,200日移動均線價格為0.20美元。
About MusclePharm
關於MusclePharm
(Get Rating)
(獲取評級)
MusclePharm Corporation develops, manufactures, markets, and distributes sports nutrition products and nutritional supplements in the United States and internationally. The company offers a range of performance powders, capsules, tablets, gels, and on-the-go ready to eat snacks. Its MusclePharm brand product portfolio includes combat protein powder and combat crunch protein bars; and essential supplements, such as a BCAA, creatine, glutamine, carnitine, CLA, fish oil, multi-vitamin, and other products.
公司在美國和國際上開發、製造、營銷和分銷運動營養品和營養補充劑。該公司提供一系列高性能粉末、膠囊、片劑、凝膠和隨時可用的零食。該公司的MusclePharm品牌產品組合包括戰鬥蛋白粉和戰鬥擠壓蛋白棒;以及支鏈氨基酸、肌酸、谷氨醯胺、肉鹼、共軛亞油酸、魚油、多種維生素和其他產品等基本補充劑。
Recommended Stories
推薦故事
- Get a free copy of the StockNews.com research report on MusclePharm (MSLP)
- Does J&J Have Enough Alpha to Be a Solid Low Beta Stock?
- This Mid Cap Energy Stock is a 10-Bagger...And May Not Be Done
- Should You Make a Reservation in Marriott International Stock?
- The Outperforming Software Stock No One is Talking About
- Will Goldman Sachs' Earnings & Revenue Beats Lift Sector Higher?
- 免費獲取StockNews.com關於MusclePharm的研究報告(MSLP)
- 強生是否有足夠的阿爾法成為穩定的低貝塔股票?
- 這隻中型股能源股是一隻10-Bagger……可能做不到
- 您需要在萬豪國際酒店預訂嗎?
- 沒有人談論的表現優異的軟件類股
- 高盛的收益和收入超出預期會提振板塊走高嗎?
Receive News & Ratings for MusclePharm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MusclePharm and related companies with MarketBeat.com's FREE daily email newsletter.
接受MusclePharm日報的新聞和評級-在下面輸入您的電子郵件地址,即可通過MarketBeat.com的免費每日電子郵件時事通訊收到對MusclePharm和相關公司的最新新聞和分析師評級的每日簡要摘要。
譯文內容由第三人軟體翻譯。